![]()
|
|
||||||||
(Received for publication, August 13, 1996, and in revised form, November 15, 1996)
From the OX40 ligand (OX40L) and OX40 are members of the
tumor necrosis factor and tumor necrosis factor receptor superfamilies,
respectively. OX40L is expressed on activated B and T cells and
endothelial cell lines, whereas OX40 is expressed on activated T cells.
A construct for mouse OX40L was expressed as a soluble protein with domains 3 and 4 of rat CD4 as a tag (sCD4-OX40L). It formed a homotrimer as assessed by chemical cross-linking and gel filtration chromatography. Radiolabeled sCD4-OX40L bound to activated mouse T
cells with a high affinity (KD = 0.2-0.4
nM) and dissociated slowly (koff = 4 × 10
Volume 272, Number 8,
Issue of February 21, 1997
pp. 5275-5282
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
§
,
,
,
Medical Research Council Cellular Immunology
Unit and the § Sir William Dunn School of Pathology,
University of Oxford, Oxford OX1 3RE, United Kingdom
5 s
1). The affinity and
kinetics of the OX40L/OX40 interactions were studied using the
BIAcoreTM biosensor, which measures macromolecular interactions in real
time. The extracellular part of the OX40 antigen was expressed as a
soluble monomeric protein and immobilized on the BIAcore sensor chip.
sCD4-OX40L bound the OX40 with a high affinity (KD = 3.8 nM), although this was lower than that determined on
the surface of activated T cells (KD = 0.2-0.4
nM), where there is likely to be less restriction in mobility of the receptor. In the reverse orientation, sOX40 bound to
immobilized sCD4-OX40L with a stoichiometry of 3.1 receptors to one
ligand, with low affinity (KD = 190 nM)
and had a relatively fast dissociation rate constant
(koff = 2 × 10
2
s
1). Thus if the OX40 receptor is cleaved by proteolysis,
it will release any bound ligand and is unlikely to block re-binding of ligand to cell surface OX40 because of the low monomeric affinity.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Newton, P. Harrison, and S. Clulow A Novel Method for Determination of the Affinity of Protein: Protein Interactions in Homogeneous Assays J Biomol Screen, August 1, 2008; 13(7): 674 - 682. [Abstract] [PDF] |
||||
![]() |
R. R. French, V. Y. Taraban, G. R. Crowther, T. F. Rowley, J. C. Gray, P. W. Johnson, A. L. Tutt, A. Al-Shamkhani, and M. J. Glennie Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation Blood, June 1, 2007; 109(11): 4810 - 4815. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Krysov, T. F. Rowley, and A. Al-Shamkhani Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells Mol. Cancer Ther., February 1, 2007; 6(2): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wilson, C. P. Rossi, S. Carboni, C. Fremaux, D. Perrin, C. Soto, M. Kosco-Vilbois, and A. Scheer A Homogeneous 384-Well High-Throughput Binding Assay for a TNF Receptor Using Alphascreen Technology J Biomol Screen, October 1, 2003; 8(5): 522 - 532. [Abstract] [PDF] |
||||
![]() |
S. Salek-Ardakani, J. Song, B. S. Halteman, A. G.-H. Jember, H. Akiba, H. Yagita, and M. Croft OX40 (CD134) Controls Memory T Helper 2 Cells that Drive Lung Inflammation J. Exp. Med., July 21, 2003; 198(2): 315 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Baba, Y. Takahashi, J. Lichtenfeld, R. Tanaka, A. Yoshida, K. Sugamura, N. Yamamoto, and Y. Tanaka Functional CD4 T Cells after Intercellular Molecular Transfer of OX40 Ligand J. Immunol., July 15, 2001; 167(2): 875 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Malmstrom, D. Shipton, B. Singh, A. Al-Shamkhani, M. J. Puklavec, A. N. Barclay, and F. Powrie CD134L Expression on Dendritic Cells in the Mesenteric Lymph Nodes Drives Colitis in T Cell-Restored SCID Mice J. Immunol., June 1, 2001; 166(11): 6972 - 6981. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Pippig, C. Pena-Rossi, J. Long, W. R. Godfrey, D. J. Fowell, S. L. Reiner, M. L. Birkeland, R. M. Locksley, A. N. Barclay, and N. Killeen Robust B Cell Immunity but Impaired T Cell Proliferation in the Absence of CD134 (OX40) J. Immunol., December 15, 1999; 163(12): 6520 - 6529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Brown, K. Boles, P. Anton van der Merwe, V. Kumar, P. A. Mathew, and A. Neil Barclay 2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48 J. Exp. Med., December 7, 1998; 188(11): 2083 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Linnell, G. Groeger, and A. B. Hassan Real Time Kinetics of Insulin-like Growth Factor II (IGF-II) Interaction with the IGF-II/Mannose 6-Phosphate Receptor. THE EFFECTS OF DOMAIN 13 AND pH J. Biol. Chem., June 22, 2001; 276(26): 23986 - 23991. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |